MT/MLT Jobs by State
Medical Laboratory Headlines
At Medlabjobs.com we don’t only help you pursue a satisfying career in the medical laboratory profession but we also provide the latest industry news.
Top Headlines
June 1, 2010 --
Context.-Celiac disease, or gluten-sensitive enteropathy, is a chronic inflammatory disorder of the small intestine characterized by...
June 1, 2010 --
Context.-Colorectal cancer is the leading cause of morbidity and death among gastrointestinal tumors and ranks fourth after lung, breast, and...
June 1, 2010 --
Context.-Colorectal cancer is the third most common cancer and the fourth most common cause of cancer death worldwide. Patient cases are...
June 1, 2010 --
Context.-Although rare, appendiceal endocrine tumors are the most common neoplasms of the appendix. Pathologic analysis is important for guiding...
June 1, 2010 --
Context.-Colorectal cancer, the most lethal long-term complication of chronic inflammatory bowel disease (IBD), is the culmination of a complex...
Researchers at Carnegie Mellon University have developed a new fluorescent biosensor that could aid in the development of an important class of drugs that target a crucial class of proteins called G protein-coupled receptors (GPCRs).
Amgen reported adjusted earnings per share (EPS) of $1.38 for the second quarter of 2010, an increase of 7 percent compared to $1.29 for the second quarter of 2009. Adjusted net income increased 1 percent to $1,326 million for the second quarter of 2010 compared to $1,311 million for the second quarter of 2009.
Insured Americans are using fewer medical services, raising questions about whether patients are consuming less health care as they pick up a greater share of the costs. The drop in usage is showing up as health-care companies report financial results. Insurers, lab-testing companies, hospitals and doctor-billing concerns say that patient visits, drug prescriptions and procedures were down in the second quarter from year-ago levels. Others say that consumers are beginning to forgo elective procedures like knee replacements.
Several Senate Republican leaders are now pushing a new, partial health-overhaul repeal bill that targets a Medicare cost-cutting panel, The Hill reports. The panel, the Independent Payment Advisory Board, would make cost-cutting recommendations whenever spending exceeds set benchmarks. Congress would have to adopt them, or come up with its own plan.
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
Other Med Lab News Sources
Site Sponsors
JungleBoards Family
We also have specialized job boards for Speech-Language Pathologists, Physical Therapists, Occupational Therapists, Doctors, Nurses, and Pharmacists. Be sure to check out our other sites: